Health Trials

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

ConditionsBlood LossIntensive CareAnastomotic LeakageLymph Node DiseaseSurvivalBlood Transfusion
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorGeneral Committee of Teaching Hospitals and Institutes, Egypt

About this trial

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

Eligibility criteria

Qualifiers

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)

Diagnosed by CT entero-colonography

Diagnosed by colonoscopy

Diagnosed by biopsy.

Disqualifiers

Emergency surgery (obstruction, perforation with generalized peritonitis),

Metastatic tumor diagnosed

ASA score of IV or higher

Need for more than one surgical procedure

Trial design

Treatments tested in this trial

  • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)
  • Enoxaparin 40 Mg/0.4 mL Injectable Solution
  • Levofloxacin 500mg
  • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

General Committee of Teaching Hospitals and Institutes, Egypt

Lead sponsor

Source ClinicalTrials.gov